LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (HKG:2291)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.72
+0.04 (0.34%)
Apr 29, 2026, 4:08 PM HKT
-54.57%
Market Cap 4.05B
Revenue (ttm) 587.50M
Net Income (ttm) 266.77M
Shares Out 346.75M
EPS (ttm) 0.77
PE Ratio 15.21
Forward PE 7.87
Dividend 0.57 (4.91%)
Ex-Dividend Date May 27, 2026
Volume 390,117
Average Volume 575,910
Open 11.71
Previous Close 11.68
Day's Range 11.67 - 11.95
52-Week Range 11.61 - 27.70
Beta -0.05
RSI 27.67
Earnings Date Aug 21, 2026

About HKG:2291

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the manufacture and sale of interventional treatment series occluders for defective congenital heart disease. It operates through Occluder Business and Heart Valve Business segments. The company also research and develops heart valve medical devices. Its products include atrial septal defect, ventricular septal defect, patent ductus arteriosus, patent foramen ovale, left atrial appendage, aortic and peripheral, and aortic and mitral valve occluder ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1994
Employees 370
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2291
Full Company Profile

Financial Performance

In 2025, HKG:2291's revenue was 527.94 million, an increase of 11.94% compared to the previous year's 471.64 million. Earnings were 239.73 million, a decrease of -2.37%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.